Results 221 to 230 of about 568,628 (266)
Lack of Association Between <i>qacE</i> and <i>qacE∆1</i> Gene Variants and Sodium Hypochlorite Resistance in Clinical Isolates of ESBL- and Carbapenemase-Producing <i>Klebsiella</i> spp. and <i>Enterobacter</i> spp., from Gaborone, Botswana. [PDF]
Ntshonga P +6 more
europepmc +1 more source
Treatment history shapes the evolution of complex carbapenem-resistant phenotypes in Klebsiella spp.
Rosas NC +18 more
europepmc +1 more source
One Health Approach to Study the Occurrence and Antimicrobial Resistance of Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella spp. in Urban Agriculture in Burkina Faso. [PDF]
Diarra FBJ +10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Antimicrobial Chemotherapy, 2021
OBJECTIVES Fosfomycin is an important antibiotic for the treatment of MDR Enterobacteriaceae infections. High susceptibility rates are, however, threatened by the spread of plasmids encoding fosfomycin-modifying enzymes.
M. Biggel +4 more
semanticscholar +1 more source
OBJECTIVES Fosfomycin is an important antibiotic for the treatment of MDR Enterobacteriaceae infections. High susceptibility rates are, however, threatened by the spread of plasmids encoding fosfomycin-modifying enzymes.
M. Biggel +4 more
semanticscholar +1 more source
Microbial Drug Resistance, 2021
Objectives: Colistin is a last-resort antibiotic for the treatment of carbapenem-resistant Gram-negative infections. Colistin resistance thus poses a threat to human health.
Yolandi Snyman +4 more
semanticscholar +1 more source
Objectives: Colistin is a last-resort antibiotic for the treatment of carbapenem-resistant Gram-negative infections. Colistin resistance thus poses a threat to human health.
Yolandi Snyman +4 more
semanticscholar +1 more source

